AU2003254001A8 - Novel htnfsf13b protein variants - Google Patents

Novel htnfsf13b protein variants

Info

Publication number: AU2003254001A8
Authority: AU; Australia
Prior art keywords: htnfsf13b; novel; protein variants; variants; protein
Prior art date: 2002-08-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003254001A

Other versions

AU2003254001A1 (en

Inventor

Derrick Ryan Witcher

Radhakrishnan Rathnachalam

Kristine Kay Kikly

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-14

Filing date

2003-08-11

Publication date

2004-03-03

2003-08-11 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

2004-03-03 Publication of AU2003254001A1 publication Critical patent/AU2003254001A1/en

2004-03-03 Publication of AU2003254001A8 publication Critical patent/AU2003254001A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Immunology (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003254001A 2002-08-14 2003-08-11 Novel htnfsf13b protein variants Abandoned AU2003254001A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US40321402P	2002-08-14	2002-08-14
US60/403,214		2002-08-14
PCT/US2003/022505 WO2004016737A2 (en)	2002-08-14	2003-08-11	Novel htnfsf13b protein variants

Publications (2)

Publication Number	Publication Date
AU2003254001A1 AU2003254001A1 (en)	2004-03-03
AU2003254001A8 true AU2003254001A8 (en)	2004-03-03

Family

ID=31888217

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003254001A Abandoned AU2003254001A1 (en)	2002-08-14	2003-08-11	Novel htnfsf13b protein variants

Country Status (2)

Country	Link
AU (1)	AU2003254001A1 (en)
WO (1)	WO2004016737A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030095967A1 (en)	1999-01-25	2003-05-22	Mackay Fabienne	BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
WO2005075511A1 (en)	2004-01-29	2005-08-18	Genentech, Inc.	Variants of the extracellular domain of bcma and uses thereof
WO2006044582A2 (en)	2004-10-13	2006-04-27	The Washington University	Use of baff to treat sepsis
EP3071024B1 (en)	2013-11-19	2018-09-05	Regeneron Pharmaceuticals, Inc.	Non-human animals having a humanized b-cell activating factor gene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6812327B1 (en) *	1996-10-25	2004-11-02	Human Genome Sciences, Inc.	Neutrokine-alpha polypeptides
US6297367B1 (en) *	1997-12-30	2001-10-02	Chiron Corporation	Polynucleotide encoding TNFL1

2003
- 2003-08-11 AU AU2003254001A patent/AU2003254001A1/en not_active Abandoned
- 2003-08-11 WO PCT/US2003/022505 patent/WO2004016737A2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2003254001A1 (en)	2004-03-03
WO2004016737A3 (en)	2006-01-05
WO2004016737A2 (en)	2004-02-26

Publication	Publication Date	Title
GB0208089D0 (en)	2002-05-22	Protein
AU2003254001A8 (en)	2004-03-03	Novel htnfsf13b protein variants
GB0201808D0 (en)	2002-03-13	Protein
PL376318A1 (en)	2005-12-27	Protein modification
AU2003278718A8 (en)	2004-03-11	Stars-a muscle-specification-binding protein
GB0220038D0 (en)	2002-10-09	Novel Protein Design
GB0202748D0 (en)	2002-03-27	Protein
GB0204735D0 (en)	2002-04-17	Protein
GB0214703D0 (en)	2002-08-07	Novel protein
GB0204736D0 (en)	2002-04-17	Protein
GB0205268D0 (en)	2002-04-17	Protein
GB0203040D0 (en)	2002-03-27	Protein
GB0203155D0 (en)	2002-03-27	Protein
GB0203156D0 (en)	2002-03-27	Protein
GB0203157D0 (en)	2002-03-27	Protein
GB0203158D0 (en)	2002-03-27	Protein
GB0203159D0 (en)	2002-03-27	Protein
GB0203160D0 (en)	2002-03-27	Protein
GB0203161D0 (en)	2002-03-27	Protein
GB0203163D0 (en)	2002-03-27	Protein
GB0203164D0 (en)	2002-03-27	Protein
GB0203165D0 (en)	2002-03-27	Protein
GB0203167D0 (en)	2002-03-27	Protein
GB0204476D0 (en)	2002-04-10	Protein
GB0202668D0 (en)	2002-03-20	Protein

Legal Events

Date	Code	Title	Description
2005-04-28	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase